TOCQUEVILLE ASSET MANAGEMENT L.P.
Position in ESPR — Esperion Therapeutics, Inc.
CIK 883961
New York, NY
Position in ESPR
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
87,000
-18.7% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $45,432,741 across 4 Drug Manufacturers - Specialty & Generic names.
All Filings in ESPR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 87,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | — | 107,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | — | 91,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | — | 63,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | — | 65,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | — | 70,000 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | — | 72,500 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | — | 77,500 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | — | 39,750 | Shares | Sole | 2024-05-09 | |
| 2020-06-30 | — | 5,500 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||